{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:39:52Z","timestamp":1760402392281,"version":"build-2065373602"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["5410001008","5410001008","5410001008"],"award-info":[{"award-number":["5410001008","5410001008","5410001008"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["104994","104994"],"award-info":[{"award-number":["104994","104994"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The growing crisis of antimicrobial resistance (AMR) underscores the critical need for innovative antimicrobial discoveries. Novel antibiotics targeting the bacterial cell wall remain an attractive area of research, due to their conservation and essentiality in bacteria and their absence in eukaryotic cells. Antibiotics targeting lipid II are of special interest due to the reduced potential for target modification of lipid components and their surface accessibility to inhibitors. In this study, we identified 3-phenyl-4-phenoxypyrazole analogues named PYO12 and PYO12a with bactericidal activity against gram-positive bacteria and low cytotoxicity for different types of mammalian cells. Gram-negative bacteria were resistant to PYO12 activity through extrusion of this compound via efflux pumps. Exposure to PYO12 induces expression of genes involved in resistance to antimicrobials targeting the cell wall, suggesting that PYO12 acts via binding to lipid II or other lipid intermediates involved in peptidoglycan or teichoic acid biosynthesis. Antagonism of PYO12 antibacterial activity by undecaprenyl-pyrophosphate supports the idea that PYO12 may bind to the lipid moiety of lipid II blocking the shuttling of peptidoglycan precursors across the cytoplasmic membrane. These findings open opportunities to further develop these compounds as antibiotics targeting bacterial cell wall synthesis.<\/jats:p>","DOI":"10.1038\/s41598-025-19561-y","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:35:01Z","timestamp":1760362501000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel antimicrobial 3-phenyl-4-phenoxypyrazole derivatives target cell wall lipid intermediates with low mammalian cytotoxicity"],"prefix":"10.1038","volume":"15","author":[{"given":"Blanca","family":"Fernandez-Ciruelos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Albanese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Femke","family":"Taverne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul W.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry M.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"19561_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"C Antimicrobial Resistance","year":"2022","unstructured":"Antimicrobial Resistance, C. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629\u2013655. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0 (2022).","journal-title":"Lancet"},{"key":"19561_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.tibtech.2010.12.006","volume":"29","author":"TD Bugg","year":"2011","unstructured":"Bugg, T. D., Braddick, D., Dowson, C. G. & Roper, D. I. Bacterial cell wall assembly: still an attractive antibacterial target. Trends Biotechnol. 29, 167\u2013173. https:\/\/doi.org\/10.1016\/j.tibtech.2010.12.006 (2011).","journal-title":"Trends Biotechnol."},{"key":"19561_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1574-6976.2007.00089.x","volume":"32","author":"A Bouhss","year":"2008","unstructured":"Bouhss, A., Trunkfield, A. E., Bugg, T. D. & Mengin-Lecreulx, D. The biosynthesis of peptidoglycan lipid-linked intermediates. FEMS Microbiol. Rev. 32, 208\u2013233. https:\/\/doi.org\/10.1111\/j.1574-6976.2007.00089.x (2008).","journal-title":"FEMS Microbiol. Rev."},{"key":"19561_CR4","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/s0021-9258(19)42861-5","volume":"249","author":"DR Storm","year":"1974","unstructured":"Storm, D. R. & Strominger, J. L. Binding of bacitracin to cells and protoplasts of micrococcus lysodeikticus. J. Biol. Chem. 249, 1823\u20131827. https:\/\/doi.org\/10.1016\/s0021-9258(19)42861-5 (1974).","journal-title":"J. Biol. Chem."},{"key":"19561_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.femsle.2004.08.033","volume":"239","author":"NE Kramer","year":"2004","unstructured":"Kramer, N. E. et al. Resistance of Gram-positive bacteria to Nisin is not determined by lipid II levels. FEMS Microbiol. Lett. 239, 157\u2013161. https:\/\/doi.org\/10.1016\/j.femsle.2004.08.033 (2004).","journal-title":"FEMS Microbiol. Lett."},{"key":"19561_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrd2004","volume":"5","author":"E Breukink","year":"2006","unstructured":"Breukink, E. & de Kruijff, B. Lipid II as a target for antibiotics. Nat. Rev. Drug Discov. 5, 321\u2013332. https:\/\/doi.org\/10.1038\/nrd2004 (2006).","journal-title":"Nat. Rev. Drug Discov"},{"key":"19561_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1042\/bj1110195","volume":"111","author":"HR Perkins","year":"1969","unstructured":"Perkins, H. R. Specificity of combination between mucopeptide precursors and Vancomycin or Ristocetin. Biochem. J. 111, 195\u2013205. https:\/\/doi.org\/10.1042\/bj1110195 (1969).","journal-title":"Biochem. J."},{"key":"19561_CR8","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1128\/AAC.37.8.1563","volume":"37","author":"M Arthur","year":"1993","unstructured":"Arthur, M. & Courvalin, P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37, 1563\u20131571. https:\/\/doi.org\/10.1128\/AAC.37.8.1563 (1993).","journal-title":"Antimicrob. Agents Chemother."},{"key":"19561_CR9","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1016\/j.jmb.2019.05.014","volume":"431","author":"F Grein","year":"2019","unstructured":"Grein, F., Schneider, T. & Sahl, H. G. Docking on lipid II-A widespread mechanism for potent bactericidal activities of antibiotic peptides. J. Mol. Biol. 431, 3520\u20133530. https:\/\/doi.org\/10.1016\/j.jmb.2019.05.014 (2019).","journal-title":"J. Mol. Biol."},{"key":"19561_CR10","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1016\/s0021-9258(19)43823-4","volume":"248","author":"DR Storm","year":"1973","unstructured":"Storm, D. R. & Strominger, J. L. Complex formation between bacitracin peptides and isoprenyl pyrophosphates. J. Biol. Chem. 248, 3940\u20133945. https:\/\/doi.org\/10.1016\/s0021-9258(19)43823-4 (1973).","journal-title":"J. Biol. Chem."},{"key":"19561_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/newbio229057a0","volume":"229","author":"RJ Watkinson","year":"1971","unstructured":"Watkinson, R. J., Hussey, H. & Baddiley, J. Shared lipid phosphate carrier in the biosynthesis of teichoic acid and peptidoglycan. Nat. New. Biol. 229, 57\u201359. https:\/\/doi.org\/10.1038\/newbio229057a0 (1971).","journal-title":"Nat. New. Biol."},{"key":"19561_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/s0021-9258(18)62540-2","volume":"246","author":"FA Troy","year":"1971","unstructured":"Troy, F. A., Frerman, F. E. & Heath, E. C. The biosynthesis of capsular polysaccharide in aerobacter aerogenes. J. Biol. Chem. 246, 118\u2013133. https:\/\/doi.org\/10.1016\/s0021-9258(18)62540-2 (1971).","journal-title":"J. Biol. Chem."},{"key":"19561_CR13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1365-2958.2011.07735.x","volume":"81","author":"A Hiron","year":"2011","unstructured":"Hiron, A., Falord, M., Valle, J., Debarbouille, M. & Msadek, T. Bacitracin and Nisin resistance in Staphylococcus aureus: a novel pathway involving the bras\/brar two-component system (SA2417\/SA2418) and both the brad\/brae and vrad\/vrae ABC transporters. Mol. Microbiol. 81, 602\u2013622. https:\/\/doi.org\/10.1111\/j.1365-2958.2011.07735.x (2011).","journal-title":"Mol. Microbiol."},{"key":"19561_CR14","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1039\/c7np00012j","volume":"34","author":"A Muller","year":"2017","unstructured":"Muller, A., Klockner, A. & Schneider, T. Targeting a cell wall biosynthesis hot spot. Nat. Prod. Rep. 34, 909\u2013932. https:\/\/doi.org\/10.1039\/c7np00012j (2017).","journal-title":"Nat. Prod. Rep."},{"key":"19561_CR15","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.bmcl.2019.04.046","volume":"29","author":"J Chauhan","year":"2019","unstructured":"Chauhan, J., Kwasny, S. M., Fletcher, S. & Opperman, T. J. Leeuw, E. P. H. Optimization of a small-molecule lipid II binder. Bioorg. Med. Chem. Lett. 29, 1849\u20131853. https:\/\/doi.org\/10.1016\/j.bmcl.2019.04.046 (2019). de.","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"19561_CR16","doi-asserted-by":"publisher","first-page":"24855","DOI":"10.1021\/jacs.4c05138","volume":"146","author":"KC Ludwig","year":"2024","unstructured":"Ludwig, K. C. et al. The dual mode of antibacterial action of the synthetic small molecule DCAP involves lipid II binding. J. Am. Chem. Soc. 146, 24855\u201324862. https:\/\/doi.org\/10.1021\/jacs.4c05138 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"19561_CR17","doi-asserted-by":"publisher","unstructured":"Reithuber, E. et al. THCz: small molecules with antimicrobial activity that block cell wall lipid intermediates. Proc. Natl. Acad. Sci. USA 118 https:\/\/doi.org\/10.1073\/pnas.2108244118 (2021).","DOI":"10.1073\/pnas.2108244118"},{"key":"19561_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/IDR.S126254","volume":"10","author":"J Malin","year":"2017","unstructured":"Malin, J., Shetty, A. C., Daugherty, S. C. & de Leeuw, E. P. Effect of a small molecule lipid II binder on bacterial cell wall stress. Infect. Drug Resist. 10, 69\u201373. https:\/\/doi.org\/10.2147\/IDR.S126254 (2017).","journal-title":"Infect. Drug Resist."},{"key":"19561_CR19","doi-asserted-by":"publisher","unstructured":"Fernandez-Ciruelos, B. et al. Repurposing Hsp90 inhibitors as antimicrobials targeting two-component systems identifies compounds leading to loss of bacterial membrane integrity. Microbiol. Spectr. e0014624 https:\/\/doi.org\/10.1128\/spectrum.00146-24 (2024).","DOI":"10.1128\/spectrum.00146-24"},{"key":"19561_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2180-11-16","volume":"11","author":"V Dengler","year":"2011","unstructured":"Dengler, V., Meier, P. S., Heusser, R., Berger-Bachi, B. & McCallum, N. Induction kinetics of the Staphylococcus aureus cell wall stress stimulon in response to different cell wall active antibiotics. BMC Microbiol. 11, 16. https:\/\/doi.org\/10.1186\/1471-2180-11-16 (2011).","journal-title":"BMC Microbiol."},{"key":"19561_CR21","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1099\/mic.0.036129-0","volume":"156","author":"CJ Balibar","year":"2010","unstructured":"Balibar, C. J. et al. cwrA, a gene that specifically responds to cell wall damage in Staphylococcus aureus. Microbiol. (Reading). 156, 1372\u20131383. https:\/\/doi.org\/10.1099\/mic.0.036129-0 (2010).","journal-title":"Microbiol. (Reading)"},{"key":"19561_CR22","doi-asserted-by":"publisher","first-page":"e69455","DOI":"10.1371\/journal.pone.0069455","volume":"8","author":"M Kawada-Matsuo","year":"2013","unstructured":"Kawada-Matsuo, M. et al. Three distinct two-component systems are involved in resistance to the class I bacteriocins, Nukacin ISK-1 and Nisin A, in Staphylococcus aureus. PLoS One. 8, e69455. https:\/\/doi.org\/10.1371\/journal.pone.0069455 (2013).","journal-title":"PLoS One"},{"key":"19561_CR23","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1046\/j.1365-2958.2003.03599.x","volume":"49","author":"M Kuroda","year":"2003","unstructured":"Kuroda, M. et al. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol. Microbiol. 49, 807\u2013821. https:\/\/doi.org\/10.1046\/j.1365-2958.2003.03599.x (2003).","journal-title":"Mol. Microbiol."},{"key":"19561_CR24","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1128\/AAC.00209-07","volume":"51","author":"M Meehl","year":"2007","unstructured":"Meehl, M., Herbert, S., Gotz, F. & Cheung, A. Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 51, 2679\u20132689. https:\/\/doi.org\/10.1128\/AAC.00209-07 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"19561_CR25","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1128\/AAC.48.8.2888-2896.2004","volume":"48","author":"T Mascher","year":"2004","unstructured":"Mascher, T., Zimmer, S. L., Smith, T. A. & Helmann, J. D. Antibiotic-inducible promoter regulated by the cell envelope stress-sensing two-component system liars of Bacillus subtilis. Antimicrob. Agents Chemother. 48, 2888\u20132896. https:\/\/doi.org\/10.1128\/AAC.48.8.2888-2896.2004 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"19561_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.foodcont.2015.06.018","volume":"59","author":"X Zhao","year":"2016","unstructured":"Zhao, X. et al. Analysis of the gene expression profile of Staphylococcus aureus treated with Nisin. Food Control. 59, 499\u2013506. https:\/\/doi.org\/10.1016\/j.foodcont.2015.06.018 (2016).","journal-title":"Food Control"},{"key":"19561_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/1471-2164-15-291","volume":"15","author":"W Schroder","year":"2014","unstructured":"Schroder, W. et al. Altering gene expression by aminocoumarins: the role of DNA supercoiling in Staphylococcus aureus. BMC Genom. 15, 291. https:\/\/doi.org\/10.1186\/1471-2164-15-291 (2014).","journal-title":"BMC Genom."},{"key":"19561_CR28","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1128\/JB.01242-09","volume":"192","author":"M Mainiero","year":"2010","unstructured":"Mainiero, M. et al. Differential target gene activation by the Staphylococcus aureus two-component system SaeRS. J. Bacteriol. 192, 613\u2013623. https:\/\/doi.org\/10.1128\/JB.01242-09 (2010).","journal-title":"J. Bacteriol."},{"key":"19561_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1574-6968.2006.00568.x","volume":"268","author":"H Kuroda","year":"2007","unstructured":"Kuroda, H., Kuroda, M., Cui, L. & Hiramatsu, K. Subinhibitory concentrations of beta-lactam induce haemolytic activity in Staphylococcus aureus through the SaeRS two-component system. FEMS Microbiol. Lett. 268, 98\u2013105. https:\/\/doi.org\/10.1111\/j.1574-6968.2006.00568.x (2007).","journal-title":"FEMS Microbiol. Lett."},{"key":"19561_CR30","doi-asserted-by":"publisher","first-page":"2254415","DOI":"10.1080\/22221751.2023.2254415","volume":"12","author":"P Gao","year":"2023","unstructured":"Gao, P. et al. SaeR as a novel target for antivirulence therapy against Staphylococcus aureus. Emerg. Microbes Infect. 12, 2254415. https:\/\/doi.org\/10.1080\/22221751.2023.2254415 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"19561_CR31","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1128\/JB.06414-11","volume":"194","author":"J Engman","year":"2012","unstructured":"Engman, J., Rogstam, A., Frees, D. & Ingmer, H. Wachenfeldt, C. The YjbH adaptor protein enhances proteolysis of the transcriptional regulator Spx in Staphylococcus aureus. J. Bacteriol. 194, 1186\u20131194. https:\/\/doi.org\/10.1128\/JB.06414-11 (2012). von.","journal-title":"J. Bacteriol."},{"key":"19561_CR32","doi-asserted-by":"publisher","unstructured":"Nielsen, T. K. et al. The Spx stress regulator confers high-level beta-lactam resistance and decreases susceptibility to last-line antibiotics in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother, e0033524  https:\/\/doi.org\/10.1128\/aac.00335-24 (2024).","DOI":"10.1128\/aac.00335-24"},{"key":"19561_CR33","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1128\/AAC.00220-13","volume":"57","author":"A Jousselin","year":"2013","unstructured":"Jousselin, A., Kelley, W. L., Barras, C., Lew, D. P. & Renzoni, A. The Staphylococcus aureus thiol\/oxidative stress global regulator Spx controls trfa, a gene implicated in cell wall antibiotic resistance. Antimicrob. Agents Chemother. 57, 3283\u20133292. https:\/\/doi.org\/10.1128\/AAC.00220-13 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"19561_CR34","doi-asserted-by":"publisher","unstructured":"Baba, T. et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2,  0008 https:\/\/doi.org\/10.1038\/msb4100050 (2006).","DOI":"10.1038\/msb4100050"},{"key":"19561_CR35","unstructured":"EUCAST.  https:\/\/www.eucast.org\/ast_of_bacteria\/mic_determination (2022)."},{"key":"19561_CR36","doi-asserted-by":"publisher","unstructured":"Evans, B. C. et al. Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs. J. Vis. Exp. e50166 https:\/\/doi.org\/10.3791\/50166 (2013).","DOI":"10.3791\/50166"},{"key":"19561_CR37","doi-asserted-by":"publisher","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402\u2013408 https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","DOI":"10.1006\/meth.2001.1262"},{"key":"19561_CR38","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568\u2013576. https:\/\/doi.org\/10.1101\/gr.129684.111 (2012).","journal-title":"Genome Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19561-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19561-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19561-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:35:02Z","timestamp":1760362502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19561-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19561"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19561-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35646"}}